ACLX
ACLX
NASDAQ · Biotechnology

Arcellx Inc

$114.69
+0.09 (+0.08%)
As of Mar 24, 9:57 PM ET ·
Financial Highlights (FY 2026)
Revenue
120.18M
Net Income
-119,524,022
Gross Margin
Profit Margin
-99.5%
Rev Growth
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 38.6% 38.6% 38.6%
Operating Margin -127.5% 7.8% 8.0% 6.7%
Profit Margin -99.5% 5.0% 4.8% 5.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 120.18M 2.26B 2.06B 2.46B
Gross Profit 873.66M 796.13M 951.80M
Operating Income -153,181,545 177.50M 165.04M 165.78M
Net Income -119,524,022 113.46M 99.51M 136.19M
Gross Margin 38.6% 38.6% 38.6%
Operating Margin -127.5% 7.8% 8.0% 6.7%
Profit Margin -99.5% 5.0% 4.8% 5.5%
Rev Growth +18.8% +20.4% -8.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 961.3K 1.10B 1.29B 1.09B
Total Equity 1.92B 1.38B 1.34B 1.34B
D/E Ratio 0.00 0.80 0.97 0.82
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -147,401,032 251.62M 213.71M 234.58M
Free Cash Flow 62.68M 52.56M 67.17M